Warrants - Additional Information (Detail) - USD ($) |
3 Months Ended | 5 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 28, 2020 |
Aug. 25, 2020 |
Mar. 31, 2020 |
Jan. 01, 2019 |
Mar. 31, 2021 |
Mar. 31, 2020 |
Feb. 01, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 30, 2019 |
Feb. 05, 2020 |
|
| Class of Warrant or Right [Line Items] | |||||||||||
| Class of warrant or right issued | 102,435 | 150,000 | 26,225 | 20,533 | 0 | 26,225 | 31,470 | ||||
| Contractual term | 7 years | 7 years | 7 years | ||||||||
| Strike price | $ 10.00 | $ 5.90 | $ 5.67 | $ 4.79 | $ 5.67 | $ 5.57 | $ 4.87 | ||||
| Fair value of warrant | $ 101,478 | $ 82,141 | $ 101,478 | $ 114,631 | $ 685,441 | ||||||
| Warrant received | $ 5,245 | ||||||||||
| Class of warrant or right vested | 21,854 | ||||||||||
| Warrant expense | $ 237,768 | $ 190,993 | $ 1,443,426 | $ 574,324 | |||||||
| Settlement transaction | 21,854 | ||||||||||
| Non-assessable shares of common stock | 13,301 | 10,050,849 | 10,050,849 | 8,180,937 | |||||||
| Class of warrant or right exercised in period | 0 | 0 | 0 | ||||||||
| First Anniversary Date Of Grant | |||||||||||
| Class of Warrant or Right [Line Items] | |||||||||||
| Fair value of warrant | $ 601,245 | ||||||||||
| Selling, General and Administrative | |||||||||||
| Class of Warrant or Right [Line Items] | |||||||||||
| Warrant expense | $ 87,597 | $ 237,768 | $ 210,848 | ||||||||
| X | ||||||||||
- Definition Class of Warrant or Right, Exercised in Period No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right issued. No definition available.
|
| X | ||||||||||
- Definition Class of Warrant or Right, Outstanding Vested No definition available.
|
| X | ||||||||||
- Definition Settlement Transaction No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. No definition available.
|
| X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|